Search clinical trials for: Fibroblast Growth Factor 23

Total 45831 results

Nidek Co. LTD.

Completed

Prospective Comparative Clinical Study to Investigate the Use of the NON CONTACT TONO/PACHYMETER NT-530P

IOP Ranges(mmHg): 7 to 16, >16 to <23, and 23 or More

Japan
UCB Pharma

Completed

Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (CERTAIN 2)

Rheumatoid Arthritis

Poland, Germany, Austria, France, Italy
Pierre Fabre Pharma GmbH
Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment (BERING)

Melanoma Stage IV | Melanoma Stage III

Austria, Germany, Switzerland
Mycovia Pharmaceuticals Inc.

Completed

Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections (ultraVIOLET)

Recurrent Vulvovaginal Candidiasis

United States
InDex Pharmaceuticals

Completed

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis (CONDUCT)

Ulcerative Colitis

Hungary, Czechia, France, Germany, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine
UCB Biopharma S.P.R.L.
Parexel

Completed

A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (CIMAX)

Axial Spondyloarthritis

Belgium, Germany, Greece, Italy, Spain, United Kingdom
UCB Korea Co., Ltd.

Completed

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Epilepsy

Korea, Republic of
UCB Pharma

Completed

A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Argentina, Australia, Belgium, Bulgaria, Canada, Chile, Croatia, Czechia, Estonia, Finland, France, Hungary, Israel, Latvia, Lithuania, Mexico, New Zealand, Russian Federation, Serbia, Slovakia, Ukraine
UCB Pharma SA
Parexel

Completed

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Rheumatoid Arthritis

Romania, United States, Australia, Austria, Bulgaria, Canada, Czechia, France, Germany, Greece, Hungary, Ireland, Italy, Mexico, Monaco, Poland, Portugal, Spain, Switzerland, United Kingdom
UCB Italy s.p.a.

Completed

Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis (SPEED)

Rheumatoid Arthritis

Italy
UCB Pharma SA

Completed

Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

Epilepsy | Partial Seizures

China
UCB Korea Co., Ltd.

Completed

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

Korea, Republic of
UCB Pharma GmbH

Completed

Observation of Treatment With Certolizumab Pegol in Daily Practice (FasT)

Rheumatoid Arthritis

Germany
Korea UCB Co., Ltd.

Completed

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (OPTIMAL)

Epilepsy

Korea, Republic of
UCB Pharma

Completed

Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support (CARE-ACT)

Idiopathic Parkinson's Disease

Germany
Francisco Selva

Completed

Effects of Magnetic Tape Over Hip Cutaneous Nerves in Patients With Low Back Pain

Low Back Pain

Spain
UCB BIOSCIENCES, Inc.

Completed

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures (ALEX-MT)

Epilepsy

Austria, United States, Australia, Canada, Denmark, France, Germany, Ireland, Italy, Poland, Puerto Rico, Spain, United Kingdom
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma

Completed

Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

Narcolepsy

Austria, Belgium, Czech Republic, Germany, Ireland, Italy, Spain, Switzerland, United Kingdom
UCB Pharma

Terminated

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Rheumatoid Arthritis | Crohn's Disease

Russian Federation
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Epilepsy | Partial Seizures

Japan
UCB Pharma
Pivotal S.L.

Completed

Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine (RETO-PD)

Parkinson's Disease

Spain
University of California, Los Angeles
Loma Linda University

Completed

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease

Secondary Hyperparathyroidism

United States
Diskapi Teaching and Research Hospital

Unknown

Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients

Fibroblast

Turkey
Diakonhjemmet Hospital
Norwegian Health Association

Completed

Refeeding Syndrome Among Older Adults (RFS)

Refeeding Syndrome

Norway
Ain Shams University

Not yet recruiting

Ameliorating Contrast Induced Nephropathy After Coronary Angiography

Coronary Artery Disease | Nephropathy; Toxic, Drugs
Cairo University

Unknown

Peritoneal Irrigation at Elective Cesarean Section

Postoperative Recovery

Egypt
Glaxo Wellcome

Completed

The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System

HIV Infections

United States
National Institute of Dental and Craniofacial Research...

Completed

Studying Phosphorus Metabolism

Phosphorus Metabolism

United States
National Institute of Public Health, Cambodia
Emory University; World Vision International; World Vision, Hong Kong; World Vision...

Completed

Innovative Nutrition and mHealth Evidence Building Project

Underweight Children Aged 6-23 Month Old (WAZ < -1)

Cambodia
Rijnstate Hospital

Completed

FGF-23 Suppressibility by Calcitonin

Hypophosphatemia

Netherlands
Nurturely

Recruiting

Carrying for the Culture

Postpartum Depression | Breast Feeding

United States
Gaziler Physical Medicine and Rehabilitation Education...

Completed

The Effects of Core Stability Training in Chronic Stroke Patients

Stroke

Turkey
Pirogov Russian National Research Medical University

Completed

Modified Method of Eversion Carotid Endarterectomy in Patients With Extensive Atherosclerotic Disease of Carotid Bifurcation

Carotid Stenosis | Carotid Artery Diseases

Russian Federation
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Fondazione Salvatore Maugeri

Completed

Acute Physiological Effects of Electronic Sigarette vs Cigarette Smoking

Individuality

Italy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cardiac Arrhythmia Pilot Study (CAPS)

Heart Diseases | Cardiovascular Diseases | Arrhythmia | Ventricular Arrhythmia
Istanbul University

Completed

Serum FGF-23 and Vitamin D Deficiency

Osteomalacia

Turkey
Eli Lilly and Company

Completed

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Psoriasis

United States, Spain, Puerto Rico, Canada, France, Korea, Republic of, Australia, Italy, Israel, Japan, Germany, Argentina, Czechia, Hungary, Poland, United Kingdom
Maimónides Biomedical Research Institute of Córdoba
Fondo de Investigacion Sanitaria

Active, not recruiting

FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.

Anemia | CKD | Fibroblast Growth Factor 23

Spain
Lumenis Be Ltd.

Completed

Caesarean Scar Revision With the UltraPulse

Scar Revision

Denmark
Eli Lilly and Company

Terminated

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Psoriasis

United States, Spain, Puerto Rico, Canada, France, Korea, Republic of, Germany, Australia, Italy, Israel, Poland, Japan, Argentina, Hungary, Taiwan, United Kingdom, Mexico, Czechia, Russian Federation
Rambam Health Care Campus

Unknown

Soft and Hard Tissue Changes Around the New Lance® Implants Using Traditional and Switch Platform Abutments

Group A- 23 Implant Using Switch Platform -SPK Abutment. | Group B- 22 Implant Using the Traditional -CPK Abutment.

Israel
Alanya Alaaddin Keykubat University

Completed

Affects of Different Vertebral Manipulation Techniques on Chronic Low Back Pain

Chronic Low-back Pain

Turkey
Statens Serum Institut

Completed

Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses (TESEC-07)

Tuberculosis

South Africa
University of Alabama at Birmingham

Completed

Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults

Healthy | Chronic Kidney Disease

United States
Huashan Hospital

Recruiting

CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging

Neurodegenerative Diseases | Alzheimer Disease | Positron Emission Tomography

China
Northwestern University
National Kidney Foundation

Completed

Iron Deficiency and FGF23 Regulation in CKD and HF (INDIGO)

Chronic Kidney Diseases | Chronic Heart Failure | Iron Deficiency Anemia

United States
Myles Wolf
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

Kidney Disease

United States
Ramathibodi Hospital

Unknown

Impact of Fibroblast Growth Factor 23 (FGF-23) and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients

Kidney Transplantation

Thailand
Eli Lilly and Company

Withdrawn

A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis (LUCENT-ACT)

Ulcerative Colitis

Search clinical trials for: Fibroblast Growth Factor 23

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations